April 16th 2021, 8:39pm
Investigators found a potential link between chronic obstructive pulmonary disease (COPD) and greater risk of experiencing stroke and myocardial infarction in patients with hypertension.
April 12th 2021, 5:00pm
Nicola Hanania, MD, MS, explains how some patients with chronic obstructive pulmonary disease (COPD) face challenges when it comes to affording treatment for the disease.
April 8th 2021, 3:00pm
A meta-analysis, where many studies ranged in evidence quality, revealed mixed results on the effectiveness of blended self-management interventions in chronic lung conditions, establishing a need for more research.
April 6th 2021, 12:35pm
Patients with chronic obstructive pulmonary disease (COPD) were found to be more likely to take medications for depression or anxiety than for other common comorbidities associated with the disease, investigators concluded.
April 2nd 2021, 9:00pm
A quality assessment program conducted in the Republic of Korea may be effective in improving disease management and prognosis for patients with chronic obstructive pulmonary disease (COPD), but the effects may be temporary.
March 30th 2021, 3:06pm
Two therapeutic regimens used for the treatment of chronic obstructive pulmonary disease (COPD) are rarely being prescribed to patients without a COPD diagnosis, investigators concluded.
March 26th 2021, 11:30am
Largely driven by hospitalizations and medications, health care costs were found to be 3 times greater for patients with chronic obstructive pulmonary disease (COPD) than for healthy individuals, according to a recent Danish study.
March 22nd 2021, 9:15pm
A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life.
March 20th 2021, 12:00pm
Patients with chronic obstructive pulmonary disease (COPD) with clinically important deterioration were found to have greater exacerbations and mortality risks; however, triplet therapy could help rectify that.
March 16th 2021, 10:45pm
After Medicare Part D plans stopped covering a chronic obstructive pulmonary disease (COPD) therapy, patients had gaps in care and increased out-of-pocket costs, according to a recent study.
